Sun Pharma and SPARC's XELPROS gets USFDA approval Medical Dialogues Bureau15 Sep 2018 11:02 AM GMTUS Food and Drug Administration (USFDA) has approved the SPARC new drug application of XELPROS, used to reduce glaucoma open-angle glaucoma or ocular...